Rubric Capital Management LP 13D and 13G filings for Ovid Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-12 06:06 am Sale |
2023-12-31 | 13G | Ovid Therapeutics Inc. OVID |
Rubric Capital Management LP | 5,315,969 7.520% |
-1,512,096 (-22.15%) |
Filing |
| 2023-02-10 4:00 pm Purchase |
2022-12-31 | 13G | Ovid Therapeutics Inc. OVID |
Rubric Capital Management LP | 6,828,065 9.690% |
6,828,065 (New Position) |
Filing |